Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.63
+0.04 (0.53%)
Dec 10, 2025, 4:00 PM EST - Market closed

Lifecore Biomedical Revenue

Lifecore Biomedical had revenue of $31.11M in the quarter ending September 30, 2025, with 25.92% growth. This brings the company's revenue in the last twelve months to $135.27M, up 5.31% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth.

Revenue (ttm)
$135.27M
Revenue Growth
+5.31%
P/S Ratio
2.06
Revenue / Employee
$317,406
Employees
406
Market Cap
285.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 25, 2025128.87M606.00K0.47%
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020160.07M-397.49M-71.29%
May 26, 2019557.56M33.33M6.36%
May 27, 2018524.23M54.45M11.59%
May 28, 2017469.78M-7.14M-1.50%
May 29, 2016476.92M-62.34M-11.56%
May 31, 2015539.26M62.44M13.10%
May 25, 2014476.81M35.11M7.95%
May 26, 2013441.71M124.16M39.10%
May 27, 2012317.55M40.82M14.75%
May 29, 2011276.73M38.51M16.16%
May 30, 2010238.22M2.29M0.97%
May 31, 2009235.94M-2.59M-1.09%
May 25, 2008238.53M28.03M13.32%
May 27, 2007210.50M-21.46M-9.25%
May 28, 2006231.95M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings